NAD Refers Star Herbs Blood Pressure Claims To FTC
This article was originally published in The Tan Sheet
The industry self-regulation group refers My Low Press supplement claims after Star Herbs fails to offer evidence to support its advertising. Referring uncooperative firms to FTC “was one of the things that we found attractive when we created our program with the NAD,” said CRN President and CEO Steve Mister.
You may also be interested in...
Claims for Summers Labs’ Triple Paste diaper rash ointment spurred Desitin maker Johnson & Johnson to bring a challenge through the National Advertising Division. Summers disagreed with NAD’s conclusion on a physician survey it conducted and declined to discontinue a doctor-recommended claim.
Under a settlement with the Federal Trade Commission announced Aug. 14, the maker of Airborne dietary supplement products must cease unsubstantiated health-related claims and contribute up to $6.5 million to an existing consumer redress fund
CRN is committing nearly half a million dollars over a three year period to triple the annual number of dietary supplement cases reviewed by the Council of Better Business Bureaus' National Advertising Division (NAD)